Journey Medical Corporation (DERM) Earnings History
Annual and quarterly earnings data from 2014 to 2024
Loading earnings history...
DERM EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
DERM Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 62.8% | -24.4% | -26.1% |
| 2023 | 66.3% | -2.6% | -4.9% |
| 2022 | 58.2% | -37.4% | -40.2% |
| 2021 | 49.2% | -55.2% | -69.7% |
| 2020 | 67.2% | 17.6% | 11.9% |
Download Data
Export DERM earnings history in CSV or JSON format
Free sign-in required to download data
Journey Medical Corporation (DERM) Earnings Overview
As of May 8, 2026, Journey Medical Corporation (DERM) reported trailing twelve-month net income of -$9M, reflecting -242.9% year-over-year growth. The company earned $-0.38 per diluted share over the past four quarters, with a net profit margin of -26.1%.
Looking at the long-term picture, DERM's historical earnings data spans multiple years. The company achieved its highest annual net income of $5M in fiscal 2020.
Journey Medical Corporation is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including SKIN (-$6M net income, -3.2% margin), PRGO (-$1.82B net income, -33.5% margin), NVCR (-$173M net income, -20.8% margin), DERM has room to improve margins relative to the peer group. Compare DERM vs SKIN →
DERM Earnings vs Peers
Earnings metrics vs comparable public companies
DERM Historical Earnings Data (2014–2024)
11 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$15M | -280.8% | -$14M | $-0.72 | -26.1% | -24.4% |
| 2023 | -$4M | +87.0% | -$2M | $-0.21 | -4.9% | -2.6% |
| 2022 | -$30M | +32.7% | -$28M | $-1.69 | -40.2% | -37.4% |
| 2021 | -$44M | -932.7% | -$35M | $-2.54 | -69.7% | -55.2% |
| 2020 | $5M | +45.7% | $8M | $0.32 | 11.9% | 17.6% |
| 2019 | $4M | +101.6% | $5M | $0.22 | 10.4% | 15.1% |
| 2018 | -$222M | +26.9% | -$214M | $-5.27 | -523.3% | -505.4% |
| 2017 | -$303M | -240.4% | -$300M | $-7.48 | -6678.3% | -6613.7% |
| 2016 | -$89M | -13.6% | -$91M | $-2.70 | -394.4% | -401.3% |
| 2015 | -$78M | -146.0% | -$80M | $-2.93 | -1074.0% | -1092.7% |
See DERM's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs DERM Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare DERM vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonDERM — Frequently Asked Questions
Quick answers to the most common questions about buying DERM stock.
Is DERM growing earnings?
DERM EPS fell to $-0.38, with earnings declining -242.9%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-9M.
What are DERM's profit margins?
Journey Medical Corporation net margin is -26.1%, with operating margin at -24.4%. Below-average margins reflect competitive or cost pressures.
How consistent are DERM's earnings?
DERM earnings data spans 2014-2024. The declining earnings trend is -242.9% YoY. Historical data enables comparison across business cycles.